BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16620785)

  • 1. AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.
    King TD; Song L; Jope RS
    Biochem Pharmacol; 2006 May; 71(11):1637-47. PubMed ID: 16620785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
    Fediuc S; Gaidhu MP; Ceddia RB
    Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo.
    Longnus SL; Ségalen C; Giudicelli J; Sajan MP; Farese RV; Van Obberghen E
    Diabetologia; 2005 Dec; 48(12):2591-601. PubMed ID: 16283248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AICAR positively regulate glycogen synthase activity and LDL receptor expression through Raf-1/MEK/p42/44MAPK/p90RSK/GSK-3 signaling cascade.
    Wang HM; Mehta S; Bansode R; Huang W; Mehta KD
    Biochem Pharmacol; 2008 Jan; 75(2):457-67. PubMed ID: 17945190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ERK1/2 by ouabain and Na-K-ATPase-dependent energy utilization and AMPK activation in parotid acinar cells.
    Soltoff SP; Hedden L
    Am J Physiol Cell Physiol; 2008 Sep; 295(3):C590-9. PubMed ID: 18632735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells.
    Woollhead AM; Sivagnanasundaram J; Kalsi KK; Pucovsky V; Pellatt LJ; Scott JW; Mustard KJ; Hardie DG; Baines DL
    Br J Pharmacol; 2007 Aug; 151(8):1204-15. PubMed ID: 17603555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway.
    Kim J; Yoon MY; Choi SL; Kang I; Kim SS; Kim YS; Choi YK; Ha J
    J Biol Chem; 2001 Jun; 276(22):19102-10. PubMed ID: 11262401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells.
    Woollhead AM; Scott JW; Hardie DG; Baines DL
    J Physiol; 2005 Aug; 566(Pt 3):781-92. PubMed ID: 15919715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.
    Jhun BS; Jin Q; Oh YT; Kim SS; Kong Y; Cho YH; Ha J; Baik HH; Kang I
    Biochem Biophys Res Commun; 2004 May; 318(2):372-80. PubMed ID: 15120611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.
    Kimura N; Tokunaga C; Dalal S; Richardson C; Yoshino K; Hara K; Kemp BE; Witters LA; Mimura O; Yonezawa K
    Genes Cells; 2003 Jan; 8(1):65-79. PubMed ID: 12558800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.
    Horike N; Sakoda H; Kushiyama A; Ono H; Fujishiro M; Kamata H; Nishiyama K; Uchijima Y; Kurihara Y; Kurihara H; Asano T
    J Biol Chem; 2008 Dec; 283(49):33902-10. PubMed ID: 18801732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
    Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
    Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
    Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
    J Biol Chem; 2002 Jul; 277(27):23977-80. PubMed ID: 11997383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Mukhtar MH; Payne VA; Arden C; Harbottle A; Khan S; Lange AJ; Agius L
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R766-74. PubMed ID: 18199594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
    Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
    J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
    Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
    Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP-activated protein kinase in metabolic control and insulin signaling.
    Towler MC; Hardie DG
    Circ Res; 2007 Feb; 100(3):328-41. PubMed ID: 17307971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
    Corton JM; Gillespie JG; Hawley SA; Hardie DG
    Eur J Biochem; 1995 Apr; 229(2):558-65. PubMed ID: 7744080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.